Neonatal Polycythemia, Presentations and Associations: A Case Control Study

Authors

  • Dlair Abdulkhaliq Chalabi Assistant professor, Hawler Medical University, College of Medicine, Pediatric Department
  • Kawes Omer Zangana Assistant professor, Hawler Medical University, College of Medicine, Pediatric Department

DOI:

https://doi.org/10.56056/amj.2018.45

Keywords:

Hematocrit, Neonates, olycythemia

Abstract

Background and objectives:Neonatal polycythemia is characterized by a venous hematocrit more than 65%. Inci- dence of neonatal polycythemia ranges from 0.4-5%, most affected infants have no clinical signs. Neonates may present by acrocyanosis, plethoric? cyanosis, respiratory distress, poor feeding or apnea. The aim of the study was to find out the prevalence of neonatal polycythemia, identify the risks and recognize most important clinical presenta- tions.

Methods:A case-control study conducted at the maternity hospital in Erbil city from 1st February 2013 to 1st May 2013. The study enrolled 500 neonates, among those neonates fifty-three of them revealed central polycythemia. The newborns were considered to be polycythemic if the venous hematocrit was greater than 65%.

Results: In this study, 53(11.85%) cases were polycythemic, 30 cases were male 36 (67.9%) with male: female ratio was 2.1:1. Poly- cythemic of less than 2 hours of age were 25 (47.2%) cases, 10 cases (18.9%) were premature. APGAR score in the first minute was less than three in 15 cases (28.3%) and this was statistically significant. Plethora was seen in seven cases, 5 (62.5%) cases in group one and 2 (15.6%) cases in group two. Severity of polycythemia was significantly related to maternal hematocrit.

Conclusions:Males were affected more than females. Jaundice was the main pres- entation followed by plethora, irritability, respiratory distress and poor feeding.

Downloads

Download data is not yet available.

References

Luchtman, JL, Wilson DB. Hematologic problems in the fetus and neonate. In: Martin RJ, Fanaroff AA, Walsh MC (Editors). Neonatal- Peri- natal Medicine. St. Louis, Elsevier Mosby, 2011: p.1303.

Garcia JA. Neonatal polycythemia. (2010). Available from, www.upto- date.com. Accessed in December 20, 2013.

Pappas A, Delaney-Black V. Differential diagnosis and management of polycythemia. Pediatr Clin N. 2004; 51: 1063–86.

Gordon EA. Polycythemia and hyperviscosity of the newborn. J Per-inat Neonatal Nurs. 2003 Jul-Sep;17(3):209-19

Sarkar S, Rosenkrantz TS. Neonatal polycythemia and hyperviscosity. Semin Fetal Neonatal Med. 2008 Aug;13(4):248-55

Kandasamy J. Polycythemia of the Newborn. 2017.Available from http://emedicine.medscape.com/article/976319-overview#a0199.

Jeevasankar M, Agarwal R, Chawla D. Polycythemia in the newborn. Indian J. Pediatr. 2008; 75: 68-72.

Rosenkrantz TS, Oh W. Polycythemia and hyperviscosity in the new- born. In: De Alarcón P., Werner E. (editors). Neonatal hematology. New York, Cambridge University Press, New York , 2005: p.983

Upadhyay A, Aggarwal R, Deorari AK. Polycythemia in the newborn. Indian J. Pediatr 2002; 69:70-82.

Mentzer W, Glader B. Erythrocyte disorders in infancy. In: Gleason C, Devaskar S (Editors). Avery’s Diseases of the Newborn. Philadelphia, WB Saunders, 2011 9th ed.: p.1080.

Sankar M, Agarwal R, Deorari A, Paul V. Management of poly- cythemia in neonates. Indian J Pediatr. 2010 Oct;77(10):1117-21

Alsafadi T, Hashmi S, Youssef H, Suliman A, Abbas H, Albaloushi,M. Polycythemia in neonatal intensive care unit, risk factors, symp- toms, pattern, and management controversy. J Clin Neonatol. 2014 Apr;3(2):93-8.

Ramamurthy R, Brans Y. Neonatal polycythemia: I. Criteria for diag- nosis and treatment. Pediatrics 1981; 68:168.

Lubetzky R, Ben-Shachar S, Mimouni FB, Dollberg S. Mode of deliv- ery and neonatal hematocrit Am J Perinatol. 2000;17(3):163-5.

Vlug R, Lopriore E, Janssen M, Middeldorp J, Rath M, Smits-Wint- jens V. Thrombocytopenia in neonates with polycythemia: incidence, risk factors and clinical outcome.Expert Rev Hematol. 2015 Feb;8(1):123-9

Lockwood CJ, Waltham MA, Ramin SM. Overview of preterm labor and birth. Up-To-Date. 2013. Available at: http://www.uptodate.com. Accessed in 16 january 2014.

Krishnan L, Rahim A. Neonatal Polycythemia. Indian J Pediatr 1997; 64:541-6.

Abbas S, Fayadh H. Neonatal Polycythemia: Risk Factors, Clinical Manifestation and Treatment Applied. The Iraqi Postgrad Medical J 2013;12: 390-5

Wexner E. Neonatal polycythemia and hyperviscosity. Clin. Perina- tol. 1995;22:693.

Singh S, Narang A , Bhakoo ON . Polycythemia in the newborn, India Pediatr . 1990; 27:349-52

Hajduczenia M, Jaremba O and Szymankiewicz M. Polycythemia of the newborn. Archives of Perinatal Medicine 2010; 16(3):127-33.

Al-Alawi E, Jenkins D. Does maternal smoking in- crease the risk of neonatal polycythemia? Ir. Med. J. 2000; 93:175-6.

Downloads

Published

2023-03-15

How to Cite

Chalabi, D. A. ., & Zangana , K. O. (2023). Neonatal Polycythemia, Presentations and Associations: A Case Control Study. AMJ (Advanced Medical Journal) , 4(1), 65-69. https://doi.org/10.56056/amj.2018.45

Issue

Vol. 4 No. 1 (2018)

Section

Articles

License

Copyright (c) 2023 Dlair Abdulkhaliq Chalabi, Kawes Omer Zangana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)